findmyKOL
Clinical trialNCT00419562CompletedPhase 3Interventional

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment560Diabetes Mellitus, Type 1
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Walter and Eliza Hall Institute

    Parkville, Victoria, Australia

Canada
  • the Hospital for Sick Children

    Toronto, Ontario, Canada

Finland
  • University of Turku

    Turku, Finland

Italy
  • San Raffaele Hospital

    Milan, Italy

United Kingdom
  • University of Bristol

    Bristol, United Kingdom

United States
  • University of California-San Francisco

    San Francisco, California, United States

  • Stanford University

    Stanford, California, United States

  • Barbara Davis Center for Childhood Diabetes

    Aurora, Colorado, United States

  • Yale University

    New Haven, Connecticut, United States

  • University of Florida

    Gainesville, Florida, United States

  • University of Miami

    Miami, Florida, United States

  • Indiana University-Riley Hospital for Children

    Indianapolis, Indiana, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Columbia University

    New York, New York, United States

  • Childrens Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt Eskind Diabetes Clinic

    Nashville, Tennessee, United States

  • University of Texas

    Dallas, Texas, United States

  • Benaroya Research Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2007
Primary completion
31 Dec 2016
Completion
30 Jun 2017
Last update posted
7 May 2020
Registered enrollment
560
Registry id
NCT00419562

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.